Infant Bacterial Therapeutics AB (publ) Stock Other OTC
Equities
Pharmaceuticals
Sales 2022 | - | Sales 2023 | 0.08 0.11 | Capitalization | 1.21B 1.67B |
---|---|---|---|---|---|
Net income 2022 | -65M -89.29M | Net income 2023 | -123M -169M | EV / Sales 2022 | - |
Net cash position 2022 | 336M 461M | Net cash position 2023 | 329M 452M | EV / Sales 2023 | 11,472,257,143 x |
P/E ratio 2022 |
-8.58
x | P/E ratio 2023 |
-9.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 12-12-31 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 22-09-18 |
Chief Operating Officer | 57 | 14-10-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 15-09-23 |
Chairman | 74 | 10-12-31 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 17-05-03 |
1st Jan change | Capi. | |
---|---|---|
+14.66% | 9.25B | |
+42.06% | 4.45B | |
-22.01% | 4.43B | |
+8.28% | 4.03B | |
+10.63% | 2.24B | |
-26.61% | 2.18B | |
+11.64% | 2.02B | |
-42.69% | 1.79B | |
-0.50% | 1.64B |